KR20010075418A - 유방 특이적으로 분비되는 유방암 단백질인 마마글로빈 - Google Patents

유방 특이적으로 분비되는 유방암 단백질인 마마글로빈 Download PDF

Info

Publication number
KR20010075418A
KR20010075418A KR1020017003944A KR20017003944A KR20010075418A KR 20010075418 A KR20010075418 A KR 20010075418A KR 1020017003944 A KR1020017003944 A KR 1020017003944A KR 20017003944 A KR20017003944 A KR 20017003944A KR 20010075418 A KR20010075418 A KR 20010075418A
Authority
KR
South Korea
Prior art keywords
mamaglobin
detecting
seq
patient
breast cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020017003944A
Other languages
English (en)
Korean (ko)
Inventor
마크 에이. 와트슨
티모씨 피. 플레밍
Original Assignee
추후제출
워싱톤 유니버시티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 추후제출, 워싱톤 유니버시티 filed Critical 추후제출
Publication of KR20010075418A publication Critical patent/KR20010075418A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020017003944A 1998-09-29 1999-09-29 유방 특이적으로 분비되는 유방암 단백질인 마마글로빈 Ceased KR20010075418A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/162,622 US6566072B1 (en) 1995-05-31 1998-09-29 Mammaglobin, a secreted mammary-specific breast cancer protein
US09/162,622 1998-09-29
PCT/US1999/022616 WO2000018783A1 (en) 1998-09-29 1999-09-29 Mammaglobin, a secreted mammary-specific breast cancer protein

Publications (1)

Publication Number Publication Date
KR20010075418A true KR20010075418A (ko) 2001-08-09

Family

ID=22586430

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017003944A Ceased KR20010075418A (ko) 1998-09-29 1999-09-29 유방 특이적으로 분비되는 유방암 단백질인 마마글로빈

Country Status (15)

Country Link
US (1) US6566072B1 (https=)
EP (1) EP1117673A4 (https=)
JP (1) JP2002525098A (https=)
KR (1) KR20010075418A (https=)
CN (1) CN1328567A (https=)
BR (1) BR9914161A (https=)
CA (1) CA2343980C (https=)
CZ (1) CZ20011025A3 (https=)
HU (1) HUP0104408A3 (https=)
IL (1) IL142079A0 (https=)
MX (1) MXPA01003240A (https=)
NO (1) NO20011394L (https=)
PL (1) PL347021A1 (https=)
TR (1) TR200101702T2 (https=)
WO (1) WO2000018783A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2282142T3 (es) * 1999-10-07 2007-10-16 Corixa Corporation Una secuencia de micobacterium tuberculosis para la expresion de proteinas heterologas.
US7009042B1 (en) * 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
PT1526187E (pt) * 2003-05-01 2008-10-16 Veridex Llc Ensaios de gânglios linfáticos intra-operatórios
WO2007141595A2 (en) * 2005-11-10 2007-12-13 Aurelium Biopharma Inc. Method of diagnosing breast cancer using protein markers
US8795359B2 (en) 2012-06-13 2014-08-05 Elwha Llc Breast implant with regionalized analyte sensors and internal power source
US9211185B2 (en) 2012-06-13 2015-12-15 Elwha Llc Breast implant with analyte sensors and internal power source
US8790400B2 (en) 2012-06-13 2014-07-29 Elwha Llc Breast implant with covering and analyte sensors responsive to external power source
US9144489B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with covering, analyte sensors and internal power source
US9144488B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with analyte sensors responsive to external power source
US8808373B2 (en) 2012-06-13 2014-08-19 Elwha Llc Breast implant with regionalized analyte sensors responsive to external power source
CN105548364B (zh) * 2015-12-10 2018-11-02 北京理工大学 热障涂层结合强度的高阶非线性参数表征方法
EP3699595A1 (en) * 2019-02-22 2020-08-26 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Use of bmmf1 rep protein as a biomarker for breast cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5573916A (en) 1994-05-19 1996-11-12 Coretech, Inc. Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
US5668267A (en) 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
WO1998007753A1 (en) * 1996-08-19 1998-02-26 Abbott Laboratories Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
WO1998021331A1 (en) * 1996-11-12 1998-05-22 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins

Also Published As

Publication number Publication date
MXPA01003240A (es) 2003-06-24
JP2002525098A (ja) 2002-08-13
IL142079A0 (en) 2002-03-10
NO20011394L (no) 2001-05-22
EP1117673A4 (en) 2004-08-04
WO2000018783A9 (en) 2000-09-21
PL347021A1 (en) 2002-03-11
WO2000018783B1 (en) 2000-05-11
CA2343980A1 (en) 2000-04-06
CN1328567A (zh) 2001-12-26
CA2343980C (en) 2012-06-26
WO2000018783A1 (en) 2000-04-06
HUP0104408A2 (hu) 2002-03-28
EP1117673A1 (en) 2001-07-25
CZ20011025A3 (cs) 2001-09-12
BR9914161A (pt) 2001-06-26
NO20011394D0 (no) 2001-03-19
HUP0104408A3 (en) 2007-05-02
US6566072B1 (en) 2003-05-20
TR200101702T2 (tr) 2001-12-21

Similar Documents

Publication Publication Date Title
US6677428B1 (en) Mammaglobin, a secreted mammary-specific breast cancer protein
US5922836A (en) Mammaglobin antigens
EP1870466A2 (en) Compositions and methods for therapy and diagnosis of prostate cancer
US7074898B2 (en) Compositions and methods for therapy and diagnosis of prostate cancer
NZ551214A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
JP2004537252A (ja) 前立腺癌の治療及び診断のための組成物及び方法
JP2002532093A (ja) 卵巣癌の治療および診断のための組成物および方法
JP2002533056A (ja) 肺癌の治療および診断のための化合物および方法
US6566072B1 (en) Mammaglobin, a secreted mammary-specific breast cancer protein
JP2002525098A5 (https=)
NZ567750A (en) Compositions and uses for cancer therapy
US20020111467A1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
US7048931B1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU767962B2 (en) Mammaglobin, a secreted mammary-specific breast cancer protein
JP2003502028A (ja) 乳癌の治療、診断およびモニタリングのための組成物および方法
US20020082216A1 (en) Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
US7270980B2 (en) Compounds for immunodiagnosis of prostate cancer and methods for their use
MXPA00002810A (en) Mammaglobin, a secreted mammary-specific breast cancer protein
CZ2000993A3 (cs) Mamaglobin, secernovaný protein specifický pro karcinom prsu
WO2001058947A9 (en) Lipophilin complexes for use in cancer diagnosis and therapy

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20010328

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20040901

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060529

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20060810

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20060529

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I